Table 3 Factors associated with mortality in HIV-infected children aged 1-5 years enrolled in the micronutrient supplementation trial in Uganda
Baseline characteristic | Unadjusted hazard ratio (95%CI) | p-value | Adjusted hazard ratio (95%CI) | p-value |
|---|---|---|---|---|
Fever | 3.7 (2.1 - 6.3) | <0.001 | 2.1 (1.1 - 3.9) | 0.02 |
Diarrhoea | 2.0 (1.0 - 3.9) | 0.05 | 1.4 (0.6 - 2.9) | 0.42 |
Cough | 2.1 (1.1 - 3.8) | 0.02 | 1.8 (0.9 - 3.5) | 0.08 |
Hospitalization (current) | 6.9 (3.6 - 13) | <0.001 | 2.6 (1.2 - 5.7) | 0.02 |
Routine cotrimoxazole | 0.4 (0.2 - 0.8) | 0.01 | 0.4 (0.2 - 0.9) | 0.03 |
Vitamin A in past 6 months | 1.4 (0.8 - 2.4) | 0.02 | 1.3 (0.7 - 2.3) | 0.39 |
WHZ score <-2 | 3.3 (1.8 - 6.0) | <0.001 | 0.8 (0.4 - 1.7) | 0.62 |
WAZ score <-2 | 5.4 (3.0 - 9.8) | <0.001 | 2.6 (1.2 - 5.8) | 0.02 |
WHO Stage 3 or 4 | 5.1 (2.9 - 9.0) | <0.001 | 2.9 (1.5 - 5.6) | <0.01 |